Study: Non-fatal VTE does not impact clinical outcomes in patients 2 years after TKA
Click Here to Manage Email Alerts
Non-fatal venous thromboembolism does not impact clinical outcomes in patients 2 years following total knee arthroplasty, according to a study from researchers from Hospital for Special Surgery.
“Patients that suffer these unfortunate complications, although at risk for significant morbidity, do not appear to have inferior clinical outcomes 2 years following surgery,” Michael P. Ast, MD, and colleagues wrote in the study. “While [venous thromboembolism] VTE events hold important clinical significance, the results of this study provide the arthroplasty surgeon with evidence of the potential clinical outcomes following these serious complications. This information can assist in counseling patients in regards to their expected outcomes after appropriate treatment for VTE following total knee arthroplasty.”
Ast and colleagues used the Hospital for Special Surgery joint registry to analyze 80 patients who experienced VTE after total knee arthroplasty (TKA) matched against 480 patients in a control group who did not have any complications. There were no significant differences between WOMAC and SF-12 scores in either group at the 2-year follow-up.
Disclosure: One author (Westrich) is a paid consultant for Stryker, Exactech and DJO and receives research support from Stryker and Exactech.